TNFSF13B and autoimmune disease: Because of their importance in B cell survival, BAFF alone (Furie et al., 2011; Navarra et al., 2011) or BAFF and APRIL (Isenberg et al., 2014; Merrill et al., 2018) have been targeted in patients with autoimmune diseases involving pathogenic auto‐reactive B cells.